State-of-the-art delirium research review: Key findings from the 2022–2023 academic year

Описание к видео State-of-the-art delirium research review: Key findings from the 2022–2023 academic year

State-of-the-art delirium research review: Key findings from the 2022–2023 academic year

Dr. Oldham reviews three of the key delirium studies published this past academic year (2022–2023). These include the 6-year outcomes of the SAGES study (Kunicki et al, JAMA Internal Medicine, 2023), the AID-ICU trial of haloperidol to treat ICU delirium (Andersen-Ranberg et al, NEJM, 2022), and the prospective 2-year CASCADE study that investigated delirium in association with neurofilament light chain (Krogseth et al, Lancet Healthy Longevity, 2023).

Комментарии

Информация по комментариям в разработке